Evaluation and management of gastric adenocarcinoma.
This article reviews the epidemiology, cause, and current staging of gastric adenocarcinoma. An in-depth discussion regarding patient assessment and treatment options is presented. Advanced disease management and clinical trials are reviewed.
Waller
M B
MB
Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. mbrame@mdanderson.org
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D000359:Aftercare; D015984:Causality; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005743:Gastrectomy / Q000379:methods; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods; D009367:Neoplasm Staging / Q000379:methods; D018579:Patient Selection; D011379:Prognosis; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D016896:Treatment Outcome